Kits Eyecare Price To Book vs. Return On Asset
| KITS Stock | CAD 10.45 0.03 0.29% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.24 | 0.3385 |
|
|
For Kits Eyecare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kits Eyecare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kits Eyecare utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kits Eyecare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kits Eyecare over time as well as its relative position and ranking within its peers.
Kits |
Kits Eyecare Return On Asset vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Kits Eyecare's current stock value. Our valuation model uses many indicators to compare Kits Eyecare value to that of its competitors to determine the firm's financial worth. Kits Eyecare is currently regarded as number one stock in price to book category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . As of the 21st of October 2024, Return On Assets is likely to drop to -0.03. Comparative valuation analysis is a catch-all model that can be used if you cannot value Kits Eyecare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kits Eyecare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Kits Return On Asset vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Kits Eyecare |
| = | 6.39 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Kits Eyecare |
| = | -0.0023 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Kits Return On Asset Comparison
Kits Eyecare is currently under evaluation in return on asset category among its peers.
Kits Eyecare Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Kits Eyecare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kits Eyecare will eventually generate negative long term returns. The profitability progress is the general direction of Kits Eyecare's change in net profit over the period of time. It can combine multiple indicators of Kits Eyecare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.1 M | -1.1 M | |
| Interest Income | 585 K | 352.2 K | |
| Operating Income | -2.4 M | -2.3 M | |
| Income Before Tax | -2.9 M | -3 M | |
| Net Loss | -4.1 M | -4.3 M | |
| Net Loss | -2.2 M | -2.3 M | |
| Net Interest Income | -975 K | -1 M | |
| Net Loss | -2.2 M | -2.3 M | |
| Total Other Income Expense Net | -484 K | -508.2 K | |
| Income Tax Expense | -676 K | -709.8 K | |
| Change To Netincome | 1.5 M | 1.9 M | |
| Net Loss | (0.07) | (0.07) | |
| Income Quality | (1.09) | (1.03) | |
| Net Income Per E B T | 0.77 | 0.62 |
Kits Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Kits Eyecare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kits Eyecare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kits Eyecare's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Kits Eyecare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Use Investing Themes to Complement your Kits Eyecare position
In addition to having Kits Eyecare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Exotic Funds Thematic Idea Now
Exotic Funds
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Kits Stock
To fully project Kits Eyecare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kits Eyecare at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kits Eyecare's income statement, its balance sheet, and the statement of cash flows.